Company Presentation • 30 Oct 2024 20:00
Company Presentation • 28 Aug 2024 20:00
Company Presentation • 01 Aug 2024 20:00
Company Presentation • 01 May 2024 20:00
Company Presentation • 07 Feb 2024 21:00
ENTITY
Neurocrine Biosciences (NBIX US)
Neurocrine Biosciences (NBIX US)
38
Analysis
Health Care • United States
Neurocrine Biosciences, Inc. is focused on the discovery and development of therapeutics for neuropsychiatric, neuroinflammatory, and neurodegenerative diseases and disorders. The Company is developing therapeutic interventions for anxiety, depression, Alzheimer's disease, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.
more
x